Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah L French

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Cell Stem Cell|August 3, 2019
Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1AFabian L Cardenas-Diaz, Catherine Osorio-Quintero, Maria A Diaz-Miranda, et al.
Plos One|May 14, 2013
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized modelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cellsStella T Chou, Marta Byrska-Bishop, Joanna M Tober, et al.
Molecular Genetics and Metabolism|December 31, 2023
A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiencyVi Pham, Livia Sertori Finoti, Margaret M Cassidy, et al.
Nature Communications|May 6, 2023
Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switchingJennine M Dawicki-McKenna, Alex J Felix, Elisa A Waxman, et al.
Blood Advances|February 9, 2021
Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradationMichelle C Krutein, Matthew R Hart, Donovan J Anderson, et al.
Stem Cell Reports|August 30, 2024
Tropomyosin 1 deficiency facilitates cell state transitions and enhances hemogenic endothelial cell specification during hematopoiesisMadison B Wilken, Gennadiy Fonar, Rong Qiu, et al.
The Journal of Clinical Investigation|May 12, 2015
Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cellsJi-Yoon Noh, Shilpa Gandre-Babbe, Yuhuan Wang, et al.
Blood|December 17, 2013
High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombastheniaSpencer K Sullivan, Jason A Mills, Sevasti B Koukouritaki, et al.
Blood|December 11, 2014
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Cell Stem Cell|August 3, 2019
Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1AFabian L Cardenas-Diaz, Catherine Osorio-Quintero, Maria A Diaz-Miranda, et al.
Plos One|May 14, 2013
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized modelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cellsStella T Chou, Marta Byrska-Bishop, Joanna M Tober, et al.
Molecular Genetics and Metabolism|December 31, 2023
A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiencyVi Pham, Livia Sertori Finoti, Margaret M Cassidy, et al.
Nature Communications|May 6, 2023
Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switchingJennine M Dawicki-McKenna, Alex J Felix, Elisa A Waxman, et al.
Blood Advances|February 9, 2021
Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradationMichelle C Krutein, Matthew R Hart, Donovan J Anderson, et al.
Stem Cell Reports|August 30, 2024
Tropomyosin 1 deficiency facilitates cell state transitions and enhances hemogenic endothelial cell specification during hematopoiesisMadison B Wilken, Gennadiy Fonar, Rong Qiu, et al.
The Journal of Clinical Investigation|May 12, 2015
Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cellsJi-Yoon Noh, Shilpa Gandre-Babbe, Yuhuan Wang, et al.
Blood|December 17, 2013
High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombastheniaSpencer K Sullivan, Jason A Mills, Sevasti B Koukouritaki, et al.
Blood|December 11, 2014
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopeniaIléana Antony-Debré, Vladimir T Manchev, Nathalie Balayn, et al.
Pageof 11